Corporate Advisory

From its inception, the NTI has integrated the advice and guidance from corporate members and advisors into its operations. The Corporate Advisory Group (CAG) embodies the commercial intent and commitment of the NTI.

The CAG comprises representatives from technology-based companies and consulting and investing firms. The CAG provides strategic direction to NTI programs, ensuring a focus on commercially relevant and realistic activities and goals. The CAG contributes an awareness of the business environment, including reports on competitive activities, strategies, and directions, and counterbalances the academic foundation of the NTI with a commercial orientation.

In addition, CAG provides a forum for technology-based companies to discuss and define their collective needs in the field of nanotechnology and to develop and implement means for financing vehicles for addressing such needs.

More specifically, the CAG participates in the discussions to develop and/or review of all funding programs, including:

• Technology Development Core program
• Technology Development Seed program
• PSTR program
• NanoApplication Fund
• Other NCG programs as appropriate

Corporate Advisory Group Members

Michael Boyce-Jacino
President & CEO
Bionanomatrix

Tauseef Butt
President
LifeSensors

David Counts
Associate Director
Angle Technologies

Edward Erickson
Consultant
Erickson Consulting

Mickey Flynn
President
PA Bio

Lisa Gray
Partner
Phoenix IP Ventures

Scott Jenkins
Associate Director, Commercial Development
Elan

Richard Barto, Ph.D.
Director
Lockheed Martin-ATL

Jeffrey Rosedale
Associate
Woodcock Washburn

Richard Wagner, Ph.D
GSK